Publish date:

'Fast Money' Recap: Intel Insider

The crew discuss the chipmaker's results with CFO Bryant and offer their trade ideas on the strong numbers.


(INTC) - Get Report

strong quarterly earnings report

and raised guidance commanded a good deal of the discussion on


"Fast Money" Tuesday evening.

Intel traded up after hours on the robust numbers. Jeff Macke likes Intel's margins and revenue estimate bump, and Guy Adami suggests buying Intel above $27 with a stop at $26.50.

Intel's CFO, Andy Bryant, joined the "Fast Money" crew to discuss the chipmaker's numbers. Bryant says the company saw the highest quarter-to-quarter revenue growth in 10 years. He also mentioned that, for now, global demand remains robust especially in Asia and Europe, and unless the world economy slows down that demand will continue into the fourth quarter.

Adami favors


(DELL) - Get Report

off this worldwide demand. Macke suggests getting into


(MSFT) - Get Report

. And Pete Najarian thinks the trade off of Intel is


(AAPL) - Get Report


Also trading higher after-hours on a strong quarterly showing was



. Najarian says Yahoo!'s U.S. revenue was very strong, and the 10% move the option market priced in was correct.

Image placeholder title

In other tech earnings, Adami says


(IBM) - Get Report

fell short a bit on gross margins and hardware revenue. But he still believes the stock is OK here. Karen Finerman says the strong technology earnings will be good news for the market.

Word on the Street

The stock market struggled Tuesday with the


dropping 71 points and oil hitting another high above $88 a barrel on geopolitical concerns that Turkey might attack Iraq. The "Fast Money" team offered their individual takes on both the day's broad market action and stock-specific news.

In the health care sector,


(BMY) - Get Report


Food and Drug Administration approval

for breast cancer treatment Ixempra. Najarian likes Bristol's cancer drug pipeline, and he believes it has a lot more behind this coming.

Adami likes


(PFE) - Get Report

into earnings. Finerman says she bought some

Biogen Idec

(BIIB) - Get Report

$85 and $90 December call options for a

takeover play


Johnson & Johnson

(JNJ) - Get Report

reported a

drop in profits

off of poor heart stent sales. Najarian says the stent business is not good but other parts of the company's business are doing OK. He isn't a big fan of the stock, however. Adami disagreed and said he likes J&J for the consumer side of the business.

Oil crossed the 88-dollar mark for the first time ever on Tuesday as the market begins to price in Turkey attacking Iraq. The teram offered their takes on this surge. Adami likes


(APA) - Get Report

on a valuation basis, and he believes it'll go to $105. Adami doesn't think the $80-to-$90 move in oil is a good thing for the overall stock market. Finerman still likes


(COP) - Get Report

for a play on rising oil prices.

Najarian noticed some unusual options activity in some regional banks on Tuesday. He is worried about the regional banks, and he says the


rate cuts haven't helped. Najarian saw heavy trading in

PNC Bank

(PNC) - Get Report

options, with 7,000 contracts trading hands for the October $65 puts. This action suggests to him that market players think PNC will drop in the next three days.

CSX Corp

(CSX) - Get Report

reported strong third-quarter earnings after the bell. Macke says the railroad stocks have pulled back and could offer a decent entry here. Adami believes CSX is a buy. Najarian says

Burlington Northern


is his favorite name in the railroad space, while Finerman has been looking at

FreightCar America

(RAIL) - Get Report



TheStreet Recommends

(T) - Get Report


hired Goldman Sachs

to look into buying


(DISH) - Get Report

. Macke continues to like EcohStar, and he loves the way the stock is acting.


(ERIC) - Get Report

crashed 24% after

issuing an earnings warning

. Ericsson CEO Carl-Henric Svanberg recently told investors that everything was great at the Swedish wireless company. Finerman says either the executive was lying or he was completely out of the loop about what was going on at the company. She believes the stock will head down again Wednesday.

Will Oil Hit $100?

With oil hitting a record high of $88, is $100 the next stop? Dennis Gartman, author of

The Gartman Letter

, joined the "Fast Money" crew to discuss his take on crude oil. Gartman doesn't believe we will get $100 oil, but if it does move that high it won't last long.

If oil reaches $100, Gartman believes it will be because of major pipeline attacks in Iraq. Gartman noted he is starting to be a buyer of natural gas here. He would play natural gas with

United States Natural Gas Fund

(UNG) - Get Report


San Juan Basin Royalty Trust

(SJT) - Get Report


Pengrowth Energy Trust



eBay Trade


(EBAY) - Get Report

is set to report earnings on Wednesday after the bell. What is the way to trade the online auction play ahead of the numbers? Macke likes the eBay into earnings. Najarian isn't seeing any action in the options on eBay right now but, he mentioned that option players have been waiting until the day of earnings to place bets.

Whale Watch in Kraft

Wall Street whale and activist shareholder

Nelson Peltz

could be ready to make some noise at



. Finerman says Peltz has a window to nominate new directors within the next 30 days. Finerman thinks a nomination will drive the stock higher if it happens. She owns Kraft personally and for her hedge fund. Adami thinks Kraft could hit $36.

Pops & Drops

Pops --



traded up 6% on a strong profits report. Macke thinks it's a great stock right here.

Bear Stearns


traded up 2% after a Chinese investment firm expressed interest in

acquiring a stake

in the brokerage. Adami says it's rich on valuation, but it's still a lottery ticket here.


(MAR) - Get Report

traded up 4% on rumors of a takeover. Najarian says this is not a pop you want to hold.

E.W. Scripps

(SSP) - Get Report

traded up 9% after the company announced plans to

split into two companies

. Macke advises selling the pop.



traded up 5% on

takeover speculation

. Finerman isn't buying the takeover rumors.

Robbins & Myers


exploded up 18% on strong fourth-quarter profits. Finerman believes this is a great earnings story.

Drops --



fell 5% after the FDA said diabetes drug Byetta

might cause pancreatitis

. Najarian says this is negative news.

Domino's Pizza

(DPZ) - Get Report

crashed 14% after taking a

hit on profits

from the rising costs of cheese and declining customer visits. Macke advises getting long beer stocks shorting pizza stocks.

Indian stocks fell after market regulators announced plans to make it harder for foreigners to purchase local firms. Adami says we could see a very dicey evening in India's market.

Final Trade

The crew signs off with their last trade ideas for the show.

  • Macke recommends Microsoft.
  • Adami suggests buying Intel.
  • Finerman favors Kraft.
  • Najarian says the options activity in EchoStar has him bullish on the satellite firm.

Stockpickr is a wholly owned subsidiary of